Form 4: Edwards Lifesciences Director Leslie C. Davis Reports Acquisition of Restricted Stock Units

Leslie C. Davis, a director at Edwards Lifesciences, reported the acquisition of 3,055 restricted stock units on May 8, 2024.

Summary

• On May 8, 2024, Leslie C. Davis, a director of Edwards Lifesciences Corp, acquired 3,055 shares of common stock in the form of restricted stock units.
• These restricted stock units were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• The units will vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.

Future Outlook

The restricted stock units are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of a director's acquisition of company stock, which is common practice in publicly traded companies to align management and shareholder interests.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively impact shareholders by aligning the director's interests with the company's long-term success.

Key Dates